First published: 28th September 2023
We are delighted to announce that Cumulus Neuroscience will present our data at the European College of Neuropsychopharmacology (ECNP) Annual Meeting in Barcelona, Spain on October 10th. The data being presented is from a biopharma customer sponsored pilot study.
Titled "A low-burden visual evoked potential measurement of neuroplasticity: real-world feasibility and data quality from an at-home pilot study," the poster was accepted by the ECNP Scientific Program Committee.
"We are excited to share data from this important pilot study that assessed the feasibility of measuring neuroplasticity in a real-world home setting using our dry sensor, FDA-cleared 16 channel EEG headset."
Brian Murphy, Ph.D.
CSO, Cumulus Neuroscience
"Today, there are several indirect ways to measure neuroplasticity including magnetic resonance imaging (MRI), traditional electroencephalography (EEG) and transcranial magnetic stimulation (TMS) however the burden on patients and health systems is high since these are costly and take time, with the result that they are rarely used in the development and deployment of drugs” said Brian Murphy, PhD, Founder and Chief Scientific Officer of Cumulus. “We are excited to share data from this important pilot study that assessed the feasibility of measuring neuroplasticity in a real-world home setting using our dry sensor, FDA-cleared 16 channel EEG headset."
Neuroplasticity refers to the brain's ability to reorganize and adapt its structure and function throughout an individual's lifespan. It involves the formation of new neural connections and the rewiring of existing ones in response to experiences, learning, and changes in the environment. This process allows the brain to compensate for injuries, learn new skills, and recover from disorders including unhealthy patterns of thinking. Neuroplasticity is a fundamental property of the brain that supports its ability to adapt and change.
Cumulus poster presentation details are as follows:
- Title: A low-burden visual evoked potential measurement of neuroplasticity: real-world feasibility and data quality from an at-home pilot study
- Date & Time: Tuesday October 10, 2023: 12:30 – 14:00 PM CEST
- Abstract Number: CG23-1395
- Poster Number: P1380
- Location: Centre Convencions Internacional de Barcelona (CCIB)
Cumulus is the co-author on a second poster accepted for presentation at ECNP in collaboration with the biopharma customer who funded the study, titled “A low-burden non-invasive measurement of neuroplasticity: feasibility for use in early drug development trials.”